VivoSeq
Other

Lice Infestation

6

Pipeline Programs↗

0

Active Trials↗

6

Companies Involved↗

Lice Infestation is an early-stage landscape with 6 programs across 6 companies. The most active players are Topaz Pharmaceuticals Inc, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Lnhc. 2 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

T

Topaz Pharmaceuticals Inc

1 program

Phase 2C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

Phase 3L

Lnhc

1 program

Phase 3A

Alliance Pharmaceuticals

1 program

ApprovedBayer logo

Bayer

1 program

ApprovedD

Deciphera Pharmaceuticals, LLC

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

12

clinical trials

Completed12 · 100%

Clinical Trials

Trial Activity

12 trials

Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
Completed·—·Phase 2·NCT01907490·38 enrolled
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Completed·—·Phase 3·NCT02060903·379 enrolled
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
Completed·TTopaz Pharmaceuticals Inc·Phase 3·NCT01066585·410 enrolled
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
Completed·BBoston Scientific Corporation·Phase 2·NCT00528021·230 enrolled
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Completed·—·Phase 2·NCT02097485·50 enrolled
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
Completed·AAlliance Pharmaceuticals·Phase 4·NCT05565820·58 enrolled
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Completed·—·Phase 3·NCT02062060·325 enrolled
Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos
Completed·UUnited Laboratories·Phase 2·NCT03286101·120 enrolled
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
Completed·PParaPRO LLC·Phase 4·NCT01660321·26 enrolled
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Completed·—·Phase 2·NCT02010333·22 enrolled
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
Completed·—·Phase 2·NCT01336647·142 enrolled
Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation
Completed·TTopaz Pharmaceuticals Inc·Phase 2·NCT00857948·78 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)